Princess Swan

Led M&A due diligence and oversaw post-acquisition integration for 5 deals, directly contributing to a 140% increase in enterprise valuation from $5B to $12B within 18 months. Partnered with C-level executives on strategic initiatives that generated $80M in new business opportunities and expanded market presence across immersive tech and media verticals.

Built and managed an investor and partner pipeline supporting $100M in capital deployment, aligning institutional investment with mission-driven growth strategies. Developed and delivered reporting frameworks for 15 bank partners, directly contributing to long-term relationship growth and capital renewals.

Sourced and led due diligence for 10 biotech and healthtech investments ranging from €20M to €100M, resulting in 3 successful acquisitions and long-term value creation. Managed investment committee processes and developed syndicates with international venture partners, contributing to €150M in total co-investment capital raised.

Partnered with the founder to develop the company’s first financial model, operational roadmap, and KPI framework, supporting early investor engagement and internal alignment. Advised on go-to-market strategy and built core workflows across product, marketing, and partnerships, accelerating the startup’s transition from concept to execution.

Promoted after 8 months from New York HQ to Frankfurt, Germany HQ to lead investor relations and special projects across global operations. Raised €50M in Series D funding and secured €12M in strategic biotech partnerships by developing financial models, investor materials, and long-term growth strategies.

Completed a Bachelor of Science degree. The curriculum provided a strong foundation in core academic principles.

Undertook a Post-Baccalaureate Research Fellowship, focusing on advanced research methodologies and contributing to academic projects. This fellowship enhanced my research and analytical skills.